Associated Papers
Classic and Nonclassic Apparent Mineralocorticoid Excess Syndrome.
Carvajal CA et al.
The Journal of Clinical Endocrinology and Metabolism, 2020
Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid-Resistant Patients.
Vitellius G et al.
The Journal of Clinical Endocrinology and Metabolism, 2019
Clinical, Biochemical, and Genetic Characteristics of "Nonclassic" Apparent Mineralocorticoid Excess Syndrome.
Tapia-Castillo A et al.
The Journal of Clinical Endocrinology and Metabolism, 2019
Alterations of Cortisol Metabolism in Human Disorders.
White PC
Hormone Research in Paediatrics, 2018
Variants of HSD11B2 gene in hypertensive disorders of pregnancy.
Kosicka K et al.
The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2017
Aldosterone synthase C-344T, angiotensin II type 1 receptor A1166C and 11-β hydroxysteroid dehydrogenase G534A gene polymorphisms and essential hypertension in the population of Odisha, India.
Patnaik M et al.
Journal of Genetics, 2014
11β-Hydroxysteroid dehydrogenase type 2 in hypertension: comparison of phenotype and genotype analysis.
Kosicka K et al.
Journal of Human Hypertension, 2013
HSD11B2 CA-repeat and sodium balance.
Mune T et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension, 2013
11β-hydroxysteroid dehydrogenase type 2 polymorphisms and activity in a Chilean essential hypertensive and normotensive cohort.
Campino C et al.
American Journal of Hypertension, 2012
Genomic epidemiology of blood pressure salt sensitivity.
Kelly TN et al.
Journal of Hypertension, 2012
The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension.
Ferrari P
Biochimica Et Biophysica Acta, 2010
Sodium sensitivity of blood pressure in Chinese populations.
Chen J
Current Hypertension Reports, 2010
Genetics of salt-sensitive hypertension.
Strazzullo P et al.
Current Hypertension Reports, 2007
Cortisol metabolism in hypertension.
Hammer F et al.
Best Practice & Research. Clinical Endocrinology & Metabolism, 2006
Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension.
Mariniello B et al.
American Journal of Hypertension, 2005
Pharmacogenomics of blood pressure response to antihypertensive treatment.
Mellen PB et al.
Journal of Hypertension, 2005
Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides.
Williams TA et al.
Kidney International, 2005
Biochemical and genetic characterization of 11 beta-hydroxysteroid dehydrogenase type 2 in low-renin essential hypertensives.
Carvajal CA et al.
Journal of Hypertension, 2005
Genetic predisposition to salt-sensitivity: a systematic review.
Beeks E et al.
Journal of Hypertension, 2004
[G protein beta 3 subunit C825T polymorphism and essential hypertension in Chinese].
Wang H et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences, 2003
Association between a variant in the 11 beta-hydroxysteroid dehydrogenase type 2 gene and primary hypertension.
Melander O et al.
Journal of Human Hypertension, 2000
Structural analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease.
Zaehner T et al.
Kidney International, 2000
Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation.
Ferrari P et al.
Kidney International, 2000
The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
Ferrari P et al.
Journal of Hypertension, 2000
Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2.
Lovati E et al.
The Journal of Clinical Endocrinology and Metabolism, 1999
Structural analysis and evaluation of the 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) gene in human essential hypertension.
Brand E et al.
Journal of Hypertension, 1998